Published in Hospital Law Weekly, March 27th, 2008
"Patients with mediastinoscopy-positive stage IIIA N2 NSCLC received 2 cycles of cisplatin 80 mg/m(2), vinorelbine 25 mg/m(2), and mitomycin-C 8 mg/m(2). Patients without progressive disease underwent thoracotomy and lobectomy with lymph node dissections 2-4 weeks later. From January 2000 to July 2004, 24 eligible patients (15 men, 9 women) were enrolled. Induction...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.